| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2004;109:1226-1229.)
© 2004 American Heart Association, Inc.
Brief Rapid Communications |
From the Division of Cardiovascular Disease, University of Alabama, Birmingham.
Correspondence to K. Nanthakumar, MD, Division of Cardiovascular Disease, 1670 University Blvd, B140 Volker Hall, Birmingham, AL 35294-0019. E-mail kn{at}crml.uab.edu
Received December 10, 2003; revision received January 20, 2004; accepted January 27, 2004.
| Abstract |
|---|
|
|
|---|
Methods and Results Among 185 patients undergoing PVI, 52 reported no significant improvement in their clinical course. We analyzed PV conduction in 51 PVs (15 patients) at repeat PVI. All PVs were isolated with either RF (30 W, 50°C, 60 seconds) or cryoablation (-80°C for 5 minutes). At repeat study, 42 of the previously isolated 51 PVs had return of conduction. All patients had recurrent conduction in
2 PVs, with only 1 non-PV focus identified. The mean number of RF applications required to re-isolate the PVs was fewer at the repeat compared with the initial procedure (10±6 versus 4±2, P<0.005). Over a period of 15±6 months, all but 1 patient was clinically improved by the second procedure.
Conclusions In patients with recurrent AF after PVI, return of PV conduction can be expected. Repeat PVI provides significant clinical benefit for these patients. These results suggest that if permanent PV isolation is the ablation strategy, different techniques may be required to improve long-term efficacy.
Key Words: mapping catheter ablation arrhythmia
| Introduction |
|---|
|
|
|---|
Recurrent AF after PVI could be related to failure to maintain conduction block from the PVs or the presence of non-PV triggering foci. If recurrent PV conduction is responsible for relapses, repeat isolation may be appropriate. In this report, we characterize PV conduction at repeat electrophysiological study in patients with recurrent AF after initially successful PVI and the outcome of a repeat procedure.
| Methods |
|---|
|
|
|---|
Initial Procedure
The electrophysiological studies were performed during intravenous sedation. Double transseptal catheterization was performed, and heparin was administered to maintain the activated clotting time >250 seconds. PV mapping was done with either a circular mapping catheter (Lasso, Webster Biosense), or a 31-mm basket catheter (Constellation, Boston Scientific). When the basket catheter was used, tirofiban was also infused. Mapping catheters were positioned in the high right atrium, superior vena cava, coronary sinus, and the PVs. Segmental isolation of all 4 PVs was performed at the initial procedure with RF (n=12) (30 W, 55°C, 60 seconds) or cryoablation (n=3) (-80°C for 5 minutes) with complete elimination or dissociation of PV potentials as the end point. The ablation was performed just outside the ostium of the pulmonary veins (determined by venography and recording of left atrial and PV electrograms). The end point was complete PVI and noninducibility of AF during isoproterenol infusion (2 to 4 µg/min) and rapid atrial pacing (cycle lengths as short as 180 ms). All patients were followed by telephone contact and in the clinic (6 weeks after ablation and every 3 months thereafter or as symptoms dictated) with serial electrocardiograms and questioned for symptoms suggestive of recurrent AF. Patients were classified as deriving no significant clinical benefit if they required AV nodal ablation, institution of amiodarone, or continued to have AF despite previously ineffective antiarrhythmic drugs.
Repeat Procedure
Patients with symptomatic recurrence were offered repeat electrophysiological study and ablation. All PVs were assessed for return of conduction. Repeat PVI was performed with the use of RF energy delivered to the PV ostium for 60 seconds, at 30 W, with a target temperature of 55°C. Isoproterenol was infused, and rapid atrial pacing was performed to a cycle length of 180 ms to assess ablation efficacy.
Statistical Analysis
Comparison of continuous variables was made by paired 2-tailed t tests.
| Results |
|---|
|
|
|---|
In patients with AF recurrence, 42 of the 51 previously isolated PVs exhibited return of electrical conduction (Table). All patients had return of conduction in
2 PVs. Fewer RF applications were required to isolate the PVs at the repeat compared with the initial procedure (10±6 versus 4±2, P=0.01). Only 1 patient had an extra-PV focus that was ablated within the vein of Marshall and also had recurrent conduction in 2 previously isolated PVs. Figure 1A illustrates PV potentials in one of the patients at initial study during AF. Figure 1B illustrates absence of PV potentials in the same left superior PV (LSPV) after 10 RF applications around its entire circumference. The patient had recurrence of AF 4 months later and underwent repeat ablation with recurrent conduction in this PV (Figure 2A). Repeat isolation required 4 RF applications to 30% of the PV circumference (Figure 2B). The only complication in this series was an asymptomatic 50% PV stenosis that remained isolated at repeat study. Among the other patients without clinical benefit after a first PVI, 13 are awaiting repeat ablation, amiodarone was started in 21, and 3 underwent AV nodal ablation.
|
|
|
Over a period of 15±2 months, 1 patient had development of permanent AF after the second PVI procedure. All other patients were clinically improved (6 on antiarrhythmic medication). There were no procedural complications from repeat ablation, and no patient has had signs or symptoms of PV stenosis.
| Discussion |
|---|
|
|
|---|
The reasons for failure of PVI include non-PV triggers and/or failure to achieve lasting PV conduction block. The present study shows that patients with recurrent AF after PVI usually have return of conduction in multiple PVs. The salutary effects of repeat PVI suggest that the resumption of left atrial (LA)-PV conduction may serve as important marker of the arrhythmogenic milieu that predisposes to AF and support repeat ablation after an initially successful procedure.
Recurrent PV Conduction in Patients With Recurrent AF
In the study by Oral et al,4 the anatomic wide-area circumferential ablation approach was compared with segmental PVI. Recurrent AF was more common with the segmental ostial ablation (32%) than after wide area circumferential left atrial ablation (10%). The amount of ablative energy was much higher with the circumferential LA ablation technique. Concordant with our findings, at repeat mapping after PVI in 7 patients, all had at least 1 PV with recurrent PV conduction. Recently, Cappato et al5 also demonstrated that PV conduction commonly recurs after PVI (80% of ablated PV ostia showed some recurrent conduction). However, clinical success after the first procedure was reported in 32% of patients despite the presence of recurrent PV conduction. This suggests that isolation may not be an absolute requirement for a successful procedure. Interestingly, greater conduction delay between the LA and the PV was observed for patients who became asymptomatic as compared with those who remained symptomatic after ablation. This suggests that though acute PVI may not be a good predictor of long-term elimination of AF, the greater the delay in PV conduction, the better the clinical outcome. It logically follows that permanent isolation would improve the results of this procedure.
Gerstenfeld et al6 reported recurrent conduction in 61% of PVs (34 patients) after PVI with 82% of patient having at least 1 PV with recurrent conduction. Importantly, this group only isolated those PVs with identifiable triggers, making it difficult to interpret the cause of recurrent AF in this population.
Why Does the Wide Area Circumferential Ablation Technique Appear to Have a Lower Recurrence Rate?
The wide area circumferential approach may provide a lower risk of recurrent AF than segmental PVI.4 However, it is unlikely that these strategies target the same physiological and anatomic substrates. Stabile et al7 demonstrated the wide area circumferential approach rarely produces PVI, suggesting that conduction block is not essential for long-term success. However, that study did not investigate whether or not the wide area circumferential approach resulted in delay in LA-PV conduction. The wide area circumferential approach uses greater RF energy (60 W for 42 minutes) than the segmental approach (30 W for 18 minutes),4 with a similar risk of complications.
Why is the wide area circumferential approach associated with a lower risk of recurrent AF? First, this technique targets a larger amount of myocardium rather than only the first few millimeters of the PV ostia. This strategy may directly ablate arrhythmogenic foci even when permanent PVI is not achieved. In addition, the PVs have a shorter refractory period than the LA, and there is often conduction delay or block of premature beats originating in the PV at the PV-left atrial junction. Circumferential ablation in the left atrium may increase this probability. The greater energy delivery should result in greater reduction in viable tissue in the zone of anisotropy.8 The segmental PVI technique has limited power delivery because of concern for the risk of PV stenosis, a factor than may predispose to recurrent PV conduction.9 It is important to point out that although acute PVI does not ensure lasting PVI and is a poor predictor of outcome, it has not been shown that AF can recur with lasting PVI of all PVs. Thus, it may be that it is the execution and not the strategy that is faulty when AF recurs after this procedure.
Conclusions
Successful PVI with previously standard target settings for RF energy or cryoablation often does not ensure lasting PVI. In patients with recurrence of AF after PVI, return of conduction can be expected in a significant number of previously isolated PVs. Repeat PVI may significantly benefit these patients. These results suggest that alternative strategies may be required to reduce the risk of recurrent AF.
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
2. Haissaguerre M, Jais P, Shah DC, et al. Catheter ablation of chronic atrial fibrillation targeting the reinitiating triggers. J Cardiovasc Electrophysiol. 2000; 11: 210.[Medline] [Order article via Infotrieve]
3. Pappone C, Rosanio S, Oreta G, et al. Circumferential radiofrequency ablation of pulmonary vein ostia: a new anatomic approach for curing atrial fibrillation. Circulation. 2000; 102: 26192628.
4. Oral H, Scharf C, Hall B, et al. Catheter ablation for paroxysmal atrial fibrillation: segmental pulmonary vein ostial ablation vs. left atrial ablation. Circulation. 2003; 108: 23552360.
5. Cappato R, Negroni S, Pecora D, et al. Prospective assessment of late conduction: recurrence across radiofrequency lesions producing electrical disconnection at the pulmonary vein ostium in patients with atrial fibrillation. Circulation. 2003; 108: 15991604.
6. Gerstenfeld EP, Callans DJ, Dixit S, et al. Incidence and location of focal atrial fibrillation triggers in patients undergoing repeat pulmonary vein isolation: implications for ablation strategies. J Cardiovasc Electrophysiol. 2003; 14: 685690.[Medline] [Order article via Infotrieve]
7. Stabile G, Turco P, La Rocca V, et al. Is pulmonary vein isolation necessary for curing atrial fibrillation? Circulation. 2003: 12; 108: 657660.
8. Hocini M, Ho SY, Kawara T, et al. Electrical conduction in canine pulmonary veins: electrophysiological and anatomic correlation. Circulation. 2002; 21: 105: 24422448.
9. Taylor GW, Kay GN, Zheng X, et al. Pathological effects of extensive radiofrequency energy applications in the pulmonary veins in dogs. Circulation. 2000; 101: 17361742.
This article has been cited by other articles:
![]() |
C. Scharf, L. Boersma, W. Davies, P. Kanagaratnam, N. S. Peters, V. Paul, E. Rowland, A. Grace, S. Fynn, L. Dang, et al. Ablation of Persistent Atrial Fibrillation Using Multielectrode Catheters and Duty-Cycled Radiofrequency Energy J. Am. Coll. Cardiol., October 6, 2009; 54(15): 1450 - 1456. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. B. Chierchia, C. de Asmundis, S.-A. Muller-Burri, A. Sarkozy, L. Capulzini, G. Paparella, S. Chierchia, M. Roos, and P. Brugada Early recovery of pulmonary vein conduction after cryoballoon ablation for paroxysmal atrial fibrillation: a prospective study Europace, April 1, 2009; 11(4): 445 - 449. [Abstract] [Full Text] [PDF] |
||||
![]() |
N Perez-Castellano, J Villacastin, J Salinas, J Moreno, M Doblado, E Ruiz, R Isa, and C Macaya Cooled ablation reduces pulmonary vein isolation time: results of a prospective randomised trial Heart, February 1, 2009; 95(3): 203 - 209. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Van Belle, P. Janse, D. Theuns, T. Szili-Torok, and L. Jordaens One year follow-up after cryoballoon isolation of the pulmonary veins in patients with paroxysmal atrial fibrillation Europace, November 1, 2008; 10(11): 1271 - 1276. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Satomi, R. Tilz, S. Takatsuki, J. Chun, B. Schmidt, D. Bansch, M. Antz, T. Zerm, A. Metzner, B. Kokturk, et al. Inducibility of atrial tachyarrhythmias after circumferential pulmonary vein isolation in patients with paroxysmal atrial fibrillation: clinical predictor and outcome during follow-up Europace, August 1, 2008; 10(8): 949 - 954. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Katritsis, M. A. Wood, E. Giazitzoglou, R. K. Shepard, G. Kourlaba, and K. A. Ellenbogen Long-term follow-up after radiofrequency catheter ablation for atrial fibrillation Europace, April 1, 2008; 10(4): 419 - 424. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Pratola, E. Baldo, P. Notarstefano, T. Toselli, and R. Ferrari Radiofrequency Ablation of Atrial Fibrillation: Is the Persistence of All Intraprocedural Targets Necessary for Long-Term Maintenance of Sinus Rhythm? Circulation, January 15, 2008; 117(2): 136 - 143. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Ulphani, R. Arora, J. H. Cain, R. Villuendas, S. Shen, D. Gordon, F. Inderyas, L. A. Harvey, A. Morris, J. J. Goldberger, et al. The ligament of Marshall as a parasympathetic conduit Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1629 - H1635. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D. Lindsay Is Pulmonary Vein Antrum Isolation a Critical Determinant of Recurrent Arrhythmias After Ablation of Atrial Fibrillation? J. Am. Coll. Cardiol., August 28, 2007; 50(9): 875 - 876. [Full Text] [PDF] |
||||
![]() |
H. Calkins, J. Brugada, D. L. Packer, R. Cappato, S.-A. Chen, H. J.G. Crijns, R. J. Damiano Jr, D. W. Davies, D. E. Haines, M. Haissaguerre, et al. HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation Developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and Approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society. Europace, June 1, 2007; 9(6): 335 - 379. [Full Text] [PDF] |
||||
![]() |
D. C. Peters, J. V. Wylie, T. H. Hauser, K. V. Kissinger, R. M. Botnar, V. Essebag, M. E. Josephson, and W. J. Manning Detection of Pulmonary Vein and Left Atrial Scar after Catheter Ablation with Three-dimensional Navigator-gated Delayed Enhancement MR Imaging: Initial Experience Radiology, March 1, 2007; 243(3): 690 - 695. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yamada, Y. Murakami, T. Okada, M. Okamoto, T. Shimizu, J. Toyama, Y. Yoshida, N. Tsuboi, T. Ito, M. Muto, et al. Incidence, location, and cause of recovery of electrical connections between the pulmonary veins and the left atrium after pulmonary vein isolation. Europace, March 1, 2006; 8(3): 182 - 188. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Essebag, F. Baldessin, M. R. Reynolds, S. McClennen, J. Shah, K. F. Kwaku, P. Zimetbaum, and M. E. Josephson Non-inducibility post-pulmonary vein isolation achieving exit block predicts freedom from atrial fibrillation Eur. Heart J., December 1, 2005; 26(23): 2550 - 2555. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Verma, F. Kilicaslan, E. Pisano, N. F. Marrouche, R. Fanelli, J. Brachmann, J. Geunther, D. Potenza, D. O. Martin, J. Cummings, et al. Response of Atrial Fibrillation to Pulmonary Vein Antrum Isolation Is Directly Related to Resumption and Delay of Pulmonary Vein Conduction Circulation, August 2, 2005; 112(5): 627 - 635. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Scherlag, W. Yamanashi, U. Patel, R. Lazzara, and W. M. Jackman Autonomically Induced Conversion of Pulmonary Vein Focal Firing Into Atrial Fibrillation J. Am. Coll. Cardiol., June 7, 2005; 45(11): 1878 - 1886. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hocini, P. Sanders, P. Jais, L.-F. Hsu, R. Weerasoriya, C. Scavee, Y. Takahashi, M. Rotter, F. Raybaud, L. Macle, et al. Prevalence of pulmonary vein disconnection after anatomical ablation for atrial fibrillation: consequences of wide atrial encircling of the pulmonary veins Eur. Heart J., April 1, 2005; 26(7): 696 - 704. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Ouyang, M. Antz, S. Ernst, H. Hachiya, H. Mavrakis, F. T. Deger, A. Schaumann, J. Chun, P. Falk, D. Hennig, et al. Recovered Pulmonary Vein Conduction as a Dominant Factor for Recurrent Atrial Tachyarrhythmias After Complete Circular Isolation of the Pulmonary Veins: Lessons From Double Lasso Technique Circulation, January 18, 2005; 111(2): 127 - 135. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |